Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey

The ICH E9(R1) addendum on Estimands and Sensitivity Analyses in Clinical Trials has introduced a new estimand framework for the design, conduct, analysis, and interpretation of clinical trials. We share Pharmaceutical Industry experiences of implementing the estimand framework in the first two year...

Descripción completa

Detalles Bibliográficos
Autores principales: Fletcher, C., Hefting, N., Wright, M., Bell, J., Anzures-Cabrera, J., Wright, D., Lynggaard, H., Schueler, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035309/
https://www.ncbi.nlm.nih.gov/pubmed/35462609
http://dx.doi.org/10.1007/s43441-022-00402-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035309/
https://www.ncbi.nlm.nih.gov/pubmed/35462609
http://dx.doi.org/10.1007/s43441-022-00402-3

Ejemplares similares